Dr Mike Hudson

Director

United Kingdom

Research Interests

cardiomyocytes, cardiac tissue models, ion channels, hERG, CiPA assay, electrophysiology

We collaborate to provide access to cardiomyocyte-based, multicellular cardiac models for research and commercial purposes. We specialise in drug safety and efficacy screening using powerful, patented DrugPrint methods and software for sophisticated analysis of electro-physiological outputs and characterisation of ion channel effects in human tissue models, with a current focus on cardiac safety.